One‐year outcomes with the HeartMate 3 left ventricular assist device

[1]  A. Haverich,et al.  First experiences with HeartMate 3 follow‐up and adverse events , 2017, The Journal of thoracic and cardiovascular surgery.

[2]  V. Rao,et al.  HeartMate 3: Better…but not perfect. , 2017, The Journal of thoracic and cardiovascular surgery.

[3]  G. Ewald,et al.  Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure , 2017, Circulation.

[4]  Ivan Netuka,et al.  Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial , 2017, Journal of Cardiothoracic Surgery.

[5]  S. Nalbantgil,et al.  Short-term Results of Heartmate 3 Ventricular Assist Device Implantation for End-Stage Heart Failure. , 2017, Transplantation proceedings.

[6]  D. Farrar,et al.  Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study. , 2017, The Annals of thoracic surgery.

[7]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[8]  M. Morshuis,et al.  Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  M. Morshuis,et al.  Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. , 2015, Journal of the American College of Cardiology.

[10]  F. Kallel,et al.  Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  Axel Haverich,et al.  First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  D. Rodgers,et al.  Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3). , 2017, The Journal of Heart and Lung Transplantation.

[13]  N. Uriel,et al.  PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.